Fuhrman Alan (CIK 1303521) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-07). Recent activity: Buy TYRA (20,000 shares), Buy TYRA (1,376 shares), Buy TYRA (701 shares), Sell SWTX (24,727 shares), Buy SWTX (10,060 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | Tyra Biosciences, Inc. (TYRA) | Chief Financial Officer | Buy | 20,000 | $0 |
| 2026-03-17 | Tyra Biosciences, Inc. (TYRA) | Chief Financial Officer | Buy | 1,376 | $12,563 |
| 2025-09-17 | Tyra Biosciences, Inc. (TYRA) | Chief Financial Officer | Buy | 701 | $6,400 |
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 24,727 | $0 |
| 2025-05-15 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Buy | 10,060 | $0 |
| 2025-03-18 | Tyra Biosciences, Inc. (TYRA) | Chief Financial Officer | Buy | 1,238 | $12,108 |
Source: SEC Form 4 filings · as of 2026-05-07